Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ELTX
ELTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELTX News
Biotech Stocks Show Significant Pre-Market Activity
2d ago
NASDAQ.COM
uniQure Shares Surge After FDA Softens Stance on Gene Therapy
2d ago
NASDAQ.COM
Elicio Therapeutics Reports Q1 2026 Loss Amid Failed Clinical Trial
3d ago
Newsfilter
Elicio Therapeutics Reports Q1 2026 Losses Amid Failed Clinical Trial
4d ago
PRnewswire
US Stocks Surge as Tech Leads Gains Amid Peace Deal
4d ago
NASDAQ.COM
Elicio Therapeutics Faces Major Setback in Cancer Drug Trial
5d ago
stocktwits
US Stocks Surge as Tech Leads Gains Amid Peace Deal
5d ago
NASDAQ.COM
Elicio Therapeutics Under Investigation for Securities Compliance
5d ago
Globenewswire
Elicio Therapeutics Phase 2 Data Misses Key Endpoint
5d ago
seekingalpha
US Stocks Surge as Oil Prices Plunge Following US-Iran Peace Deal
5d ago
NASDAQ.COM
Biotech Stocks Show Significant Pre-Market Activity
5d ago
NASDAQ.COM
Elicio Grants 21,210 Stock Options to New Employee
Apr 16 2026
Yahoo Finance
Elicio Therapeutics Reports FY GAAP EPS and Cash Position
Mar 12 2026
seekingalpha
Elicio Therapeutics Grants 22,400 Stock Options to Attract New Employees
Jan 16 2026
Yahoo Finance
Elicio Grants 157,193 Stock Options to Attract New Employees
Dec 16 2025
Newsfilter
Elicio Announces Robust T Cell Responses in Phase 2 Cancer Vaccine Trial
Sep 17 2025
NASDAQ.COM
Show More News
